Finance

Lists
Why is 532872 up 2,54%?
Dive Deeper
532872:BOM
Sun Pharma Advanced Research Co Ltd
₹193,50
+2,54%
(+4,80) 1D
14 Okt., 12:46:57 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532872...
Open
₹188,70
High
₹198,20
Low
₹188,70
Mkt. cap
62,79 mjd
Avg. vol.
87,06 k
Volume
111,82 k
P/E ratio
3,96
52-wk high
₹289,00
52-wk low
₹108,20
EPS
₹48,91
Shares outstanding
255,99 m
No. of employees
279
Open
₹188,70
High
₹198,20
Low
₹188,70
Mkt. cap
62,79 mjd
Avg. vol.
87,06 k
Volume
111,82 k
P/E ratio
3,96
52-wk high
₹289,00
52-wk low
₹108,20
EPS
₹48,91
Shares outstanding
255,99 m
No. of employees
279
News stories
From web sources and news partners
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees279
Founded2007
Headquarters-
SectorPharmaceutical industry
Websitesparc.life
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
78,60 m
84,50 m
18,53 mjd
399,20 m
Cost of goods sold
61,00 m
72,10 m
115,06 m
76,60 m
Cost of revenue
61,00 m
72,10 m
115,06 m
76,60 m
Research and development expenses
80,10 m
62,70 m
28,44 m
132,60 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
483,40 m
424,60 m
557,37 m
448,00 m
Operating expense
700,40 m
604,50 m
605,33 m
684,60 m
Total operating expenses
761,40 m
676,60 m
720,39 m
761,20 m
Operating income
-682,80 m
-592,10 m
17,81 mjd
-362,00 m
Other non operating income
100,00 k
-
-116,03 m
236,60 m
EBT including unusual items
-757,90 m
-803,50 m
17,61 mjd
-206,70 m
EBT excluding unusual items
-757,90 m
-679,90 m
17,61 mjd
-206,70 m
Income tax expense
600,00 k
700,00 k
-3,84 m
1,10 m
Effective tax rate
-0,08%
-0,09%
-0,02%
-0,53%
Other operating expenses
111,30 m
91,50 m
-3,44 m
82,00 m
Net income
-758,50 m
-804,20 m
17,61 mjd
-207,80 m
Net profit margin
-965,01%
-951,72%
95,04%
-52,05%
Earnings per share
-
-
-
-
Interest and investment income
-
-
102,87 m
-
Interest expense
-75,20 m
-87,80 m
-90,07 m
-81,30 m
Net interest expenses
-75,20 m
-87,80 m
12,80 m
-81,30 m
Depreciation and amortization charges
25,60 m
25,70 m
22,96 m
22,00 m
EBITDA
-656,60 m
-570,75 m
17,83 mjd
-342,34 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme